14. Drugs for Diabetes and Obesity
Sheila A Doggrell
Discipline of Medical Sciences, Faculty of Science and Technology, Queensland University of Technology, Gardens Point, GPO Box 2434, QLD 4001, Australia
Phone +61 7 38705741 Fax +61 7 31381534 Email sheila.doggrell@qut.edu.au
Reviewer: Petra Czarniak, Curtin University of Technology, Perth
Key words: diabetes, Type 1 diabetes, Type 2 diabetes, physiology of the pancreas, insulin replacement therapy, metformin, acarbose, sulfonylureas, glitazones, glucagon-like peptide-1, exenatide, sitagliptin, obesity, amphetamine, phentermine, orlistat
Contents
14.1 Drugs for diabetes
14.1.1 Diabetes mellitus
14.1.2 Physiology of the pancreas
14.1.3 Insulin replacement therapy
14.1.4 Metformin
14.1.5 Acarbose
14.1.6 Sulfonylureas
14.1.7 Glitazones
14.1.8 Glucagon-like peptide-1, exenatide and sitagliptin
14.2 Drugs for obesity
14.2.1 Introduction
14.2.2 Amphetamine
14.2.3 Phentermine
14.2.5 Orlistat